Drug
Orelabrutinib Rifampin
Orelabrutinib Rifampin: highest development phase Phase 1, developed by InnoCare Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- InnoCare Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Orelabrutinib + Rifampin NCT05316857 | Phase 1 | Healthy Person |
Latest
No recent events.
Follow Orelabrutinib Rifampin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.